InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,222.68
(
0.16%
)
US TECH 100
17,650.00
(
0.05%
)
Dow Jones
39,512.84
(
0.32%
)
Brent Oil
82.59
(
0.00%
)
Bitcoin
61,247.53
(
0.74%
)
Post# of 1509
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

joseytheoutlawwales

Send PM Follow Ignore
Followers 132
Posts 7818
Boards Moderated 0
Alias Born 12/17/2009

joseytheoutlawwales

Re: Citrati post# 129

Wednesday, 09/13/2017 7:22:38 PM

Wednesday, September 13, 2017 7:22:38 PM

Post# of 1509
No problem, C.

I truly like the Algovita system, and I rank it #2 behind Boston Scientific; across the entire marketplace.

THAT is the reason to invest in NVTR, instead of Boston Sci.

Reasoning- for being "#2" in terms of quality, their market cap is currently ranking them in LAST PLACE.

I still honestly believe in an eventual 1-2 billion valuation, OR a buyout in range of 500 million- 1.5 billion---based on tech and IP alone.

Just not certain how long that will take.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up